The treatment of HNSCC cells by mTOR inhibitor, Rapamycin alone, has led to no visible changes in LC3B-II level, while the treatment of Rapamycin in combination with CQ demonstrated an increase in the level of LC3B-II, suggesting an activation of autophagy. Here, MTOR is linked to head and neck squamous cell carcinoma.